Arbutus Biopharma Corp (ABUS)

May 22, 2026

Arbutus Posts Profit After Moderna Patent Settlement - MyChesCo

May 22, 2026

May 22, 2026

ABUS Stock Price, Quote & Chart | ARBUTUS BIOPHARMA CORP (NASDAQ:ABUS) - ChartMill

May 22, 2026

May 15, 2026

Two Seas (NASDAQ: ABUS) reports 18.56M Arbutus shares; 9.4% stake - Stock Titan

May 15, 2026

May 13, 2026

Arbutus Biopharma Corp Q1 2026 Financial Results and Business Update – Clinical Progress in Hepatitis B Therapies - Minichart

May 13, 2026

May 13, 2026

Arbutus Biopharma Corporation 8-K Filing: Company Details, Financial Data, and NASDAQ Listing (May 2026) - Minichart

May 13, 2026

May 13, 2026

Is Arbutus Biopharma (ABUS) Overvalued After Q1 2026 Earnings Be - GuruFocus

May 13, 2026

May 13, 2026

Arbutus Biopharma (ABUS) Reports Strong Q1 Earnings with $0.87 E - GuruFocus

May 13, 2026

May 13, 2026

Arbutus Biopharma Corp reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2026

May 13, 2026

Arbutus Biopharma earnings beat by $0.91, revenue topped estimates - Investing.com

May 13, 2026

May 13, 2026

Arbutus Biopharma Corp 1Q 2026: Revenue $179.13M, EPS $0.87— 10-Q Summary - TradingView

May 13, 2026

May 13, 2026

Arbutus: Q1 Earnings Snapshot - 10TV

May 13, 2026

May 13, 2026

Moderna settlement drives Arbutus (NASDAQ: ABUS) to $169.7M Q1 profit - Stock Titan

May 13, 2026

May 13, 2026

Arbutus (NASDAQ: ABUS) swings to Q1 profit on $179M revenue surge - Stock Titan

May 13, 2026

May 13, 2026

Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update - Stock Titan

May 13, 2026

May 13, 2026

Arbutus Biopharma: A Fascinating HBV Story, But Still Too Early (NASDAQ:ABUS) - Seeking Alpha

May 13, 2026

May 10, 2026

MSN Money - MSN

May 10, 2026

May 08, 2026

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

May 08, 2026

May 06, 2026

Arbutus Biopharma (ABUS) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

May 06, 2026

May 01, 2026

Arbutus Biopharma (ABUS): 10 Best Biotech Penny Stocks to Buy in 2026 - Insider Monkey

May 01, 2026

Apr 30, 2026

5 Best Biotech Penny Stocks to Buy in 2026 - Insider Monkey

Apr 30, 2026

Apr 28, 2026

Whitefort lifts Arbutus (ABUS) economic stake to 9.8% - Stock Titan

Apr 28, 2026

Apr 24, 2026

Arbutus Biopharma (NASDAQ:ABUS) Shares Cross Above 200-Day Moving AverageHere's What Happened - MarketBeat

Apr 24, 2026

Apr 23, 2026

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran - Insider Monkey

Apr 23, 2026

Apr 22, 2026

Arbutus Drug Candidate Receives FDA Fast Track Designation - MyChesCo

Apr 22, 2026

Apr 21, 2026

ABUS (Arbutus Biopharma) Other Liabilities for Banks - GuruFocus

Apr 21, 2026

Apr 21, 2026

FDA grants Arbutus Biopharma drug fast track designation - Pennsylvania Business Report -

Apr 21, 2026

Apr 20, 2026

Arbutus (ABUS) Stock: Stability Assessment (Momentum Fading) 2026-04-20Trending Momentum Stocks - newser.com

Apr 20, 2026

Apr 18, 2026

Form 10-KAnnual report [Section 13 and 15(d), not S-K Item 405] - ADVFN

Apr 18, 2026

Apr 17, 2026

Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability - Insider Monkey

Apr 17, 2026

Apr 17, 2026

QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Sahm

Apr 17, 2026

Apr 16, 2026

Whitefort Capital Management, LP Increases Stake in Arbutus Biop - GuruFocus

Apr 16, 2026

Apr 16, 2026

Why J B Hunt Transport Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 16, 2026

Apr 15, 2026

Arbutus Biopharma (ABUS) Receives FDA Fast Track Designation for Imdusiran - GuruFocus

Apr 15, 2026

Apr 15, 2026

Arbutus Biopharma Corp ($ABUS) Former Interim President and CEO 2025 Pay Revealed - Quiver Quantitative

Apr 15, 2026

Apr 15, 2026

Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume IncreaseHere's Why - MarketBeat

Apr 15, 2026

Apr 15, 2026

Arbutus Biopharma Corporation Files Form 8-K with SEC – Company Details, Address, and NASDAQ Listing Information 24252675 - Minichart

Apr 15, 2026

Apr 15, 2026

ABUS Receives Fast Track Designation from FDA for Imdusiran - GuruFocus

Apr 15, 2026

Apr 15, 2026

Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B - The Manila Times

Apr 15, 2026

Apr 15, 2026

[8-K] Arbutus Biopharma Corp Reports Material Event - Stock Titan

Apr 15, 2026

Apr 14, 2026

Arbutus Biopharma (ABUS) 2026 proxy adds 16.3M-share incentive plan vote - Stock Titan

Apr 14, 2026

Apr 13, 2026

Whitefort outlines 8.1% Arbutus Biopharma (ABUS) stake in amended 13D - Stock Titan

Apr 13, 2026

Apr 10, 2026

ABUS Technical Analysis | Trend, Signals & Chart Patterns | ARBUTUS BIOPHARMA CORP (NASDAQ:ABUS) - ChartMill

Apr 10, 2026

Apr 09, 2026

Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat

Apr 09, 2026

Apr 08, 2026

Arbutus reports results, announces $2.25B Moderna settlement - MSN

Apr 08, 2026

Apr 07, 2026

ABUS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 07, 2026